http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111408019-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd10e871d9be380058ebd3c6fc7b873c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-105 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-10181 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1011 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 |
| filingDate | 2020-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17c02d248c41af2af228a8d2e1932fff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e02859825add9e4f8484ef24313d7a53 |
| publicationDate | 2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111408019-A |
| titleOfInvention | Drug release balloon catheter and drug release method thereof |
| abstract | The invention provides a drug release balloon catheter and a drug release method thereof, wherein a second balloon of the drug release balloon catheter comprises a first area, a second area arranged at the proximal end of the first area and a third area arranged at the distal end of the first area, at least one micropore is formed in the first area, the second balloon is in an expansion state during drug release, the diameter of the first area is smaller than that of the second area and smaller than that of the third area, the second area and the third area are both attached to the inner wall of a cavity channel, and a drug release space is formed by the first area and the inner wall of the cavity channel in an enclosing manner. The liquid medicine can not be lost or hardly lost in the medicine release space, and the fluid outside the medicine release space can not enter the medicine release space, so that the liquid medicine in the medicine release space can be fully used for treating the pathological part, the transfer rate is increased, and the accurate medicine delivery is realized. In addition, the risk of cavity blockage caused by liquid medicine loss and large metabolic burden of the organism is reduced. |
| priorityDate | 2020-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 116.